Characteristics of women with ever-asthma from the Asthma-E3N study according to disease activity and the use of nonasthma medications
| Whole population | Women with current asthma | Women with past asthma | Women with nonasthma medications | Women without nonasthma medications | p-value# | p-value¶ | |
| Women | 4328 | 3023 | 1305 | 4084 | 244 | ||
| Sociodemographic characteristics | |||||||
| Age years | 69.6±6.1 | 69.9±6.1 | 69.1±6.0 | 69.4±6.0 | 71.3±7.1 | <0.0001 | <0.0001 |
| BMI kg·m−2 | |||||||
| <20 | 431 (10.9) | 287 (10.4) | 144 (12.2) | 406 (10.9) | 25 (11.2) | <0.0001 | 0.78 |
| 20–25 | 2082 (52.9) | 1354 (49.2) | 728 (61.4) | 1968 (53.0) | 114 (50.9) | ||
| 25–30 | 1035 (26.3) | 775 (28.2) | 260 (21.9) | 970 (26.2) | 65 (29.0) | ||
| ≥30 | 389 (9.9) | 335 (12.2) | 54 (4.5) | 369 (9.9) | 20 (8.9) | ||
| Educational level | |||||||
| Less than high school diploma | 449 (10.8) | 319 (11.0) | 130 (10.3) | 367 (9.3) | 82 (34.2) | 0.08 | <0.0001 |
| High school to level 2 university | 2050 (49.2) | 1462 (50.3) | 588 (46.8) | 1974 (50.3) | 76 (31.6) | ||
| Level 3/4 university | 840 (20.2) | 562 (19.3) | 278 (22.1) | 800 (20.4) | 40 (16.7) | ||
| Level ≥5 university | 826 (19.8) | 564 (19.4) | 262 (20.8) | 784 (20.0) | 42 (17.5) | ||
| Smoking | |||||||
| Never-smoker | 2152 (50.1) | 1494 (49.9) | 658 (50.8) | 2028 (50.1) | 124 (50.6) | 0.45 | 0.96 |
| Ex-smoker | 1975 (46.0) | 1380 (46.0) | 595 (45.9) | 1864 (46.1) | 111 (45.3) | ||
| Current smoker | 166 (3.9) | 123 (4.1) | 43 (3.3) | 156 (3.8) | 10 (4.1) | ||
| Asthma | |||||||
| Asthma symptoms | |||||||
| 0 | 1248 (37.5) | 177 (7.8) | 1071 (100.0) | 1180 (37.5) | 68 (37.3) | <0.0001 | 0.29 |
| 1 | 891 (26.7) | 891 (39.4) | 0 (0) | 849 (26.9) | 42 (23.1) | ||
| 2 | 488 (14.6) | 488 (21.6) | 0 (0) | 464 (14.7) | 24 (13.2) | ||
| ≥3 | 705 (21.2) | 705 (31.2) | 0 (0) | 657 (20.9) | 48 (26.4) | ||
| Parental asthma | 960 (23.8) | 695 (24.8) | 265 (21.5) | 905 (23.7) | 55 (24.9) | 0.02 | 0.70 |
| Drugs for asthma (ATC code R03) | 2366 (54.7) | 1971 (65.2) | 395 (30.3) | 2366 (58.0) | 0 (0) | <0.0001 | <0.0001 |
| Medical follow-up over the last 12 months | 1306 (33.1) | 1220 (44.9) | 86 (7.0) | 1216 (32.7) | 90 (40.5) | <0.0001 | 0.02 |
| Regular monitoring for asthma | 733 (18.3) | 683 (24.7) | 50 (4.0) | 684 (18.1) | 49 (22.3) | <0.0001 | 0.12 |
| General practitioner | 1188 (30.9) | 1100 (41.9) | 88 (7.2) | 1105 (30.5) | 83 (38.4) | <0.0001 | 0.01 |
| Specialist | 826 (21.7) | 757 (29.3) | 69 (5.6) | 765 (21.2) | 61 (29.8) | <0.0001 | 0.004 |
Data are presented as n, mean±sd or n (%), unless otherwise stated. BMI: body mass index; ATC: Anatomical Therapeutic Chemical. #: comparing women with current asthma and women with past asthma; ¶: comparing women with nonasthma medications and women without nonasthma medications.